Other ASH Meetings

Other ASH Meetings

Highlights and interviews from the American Society of Hematology’s meetings

Harnessing the Power of Gene Editing

For years, scientists have been manipulating genes in animal and human cells to gain a better understanding of how genomes work, with an eye...

ASH Sickle Cell Disease Summit: A Call to Action

In mid-April, more than 60 experts in sickle cell disease (SCD), including clinicians and researchers, federal agency partners, representatives from industry, and other members...
Advertisement

Current Issue

July 2017, Volume 3, Issue 8

This issue features an interview with the FDA's Richard Pazdur, highlights from the 2017 ASCO Annual Meeting, a debate about minimal residual disease in myeloma, and more.